Two years in­to an R&D over­haul, GSK plans $250M lab project near Philly for an­oth­er mi­gra­tion of US staffers

Glax­o­SmithK­line set out to com­plete­ly over­haul its US R&D or­ga­ni­za­tion in late 2014, ax­ing hun­dreds of staffers in its long­time drug in­ves­ti­ga­tion cen­ter in Re­search …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.